Enhances global capabilities for life science and healthcare industry
DHL Global Forwarding continues to enhance its global capabilities for the life science and healthcare industries by expanding its network of Envirotainer QEP certified sites. The proper and expert handling of the ‘Envirotainer’ ’ a temperature and humidity-controlled air cargo container ’ is critical to successfully transporting climate sensitive products. DHL has enhanced its capabilities for meeting the temperature-sensitive requirements for customers at additional airport facilities in the US, Canada and Europe where the majority of volumes are transported for the life science and healthcare industries.
DHL leads the development of cold chain solutions, including temperature controlled package handling, in-transit visibility to shipments and best-in-class controlled environments for cold chain storage.
DHL personnel are now trained and certified by Envirotainer, a leading provider of temperature-controlled air cargo containers, for safe and proper handling of its containers for customers with temperature sensitive products at major airports across North America, including New York, Chicago, Atlanta, Miami, Charlotte, and Los Angeles; Toronto and Montreal in Canada; and cities in Europe including Amsterdam, Basel, Brussels, Dublin, Frankfurt, London, Manchester, Milan, Muenster, Paris, Rome, Shannon, Stuttgart and Vienna.
DHL has gained Qualified Envirotainer Provider (QEP) accreditation, comprised of training and audits on proper material handling of the Envirotainers, as well as use of associated equipment including power supplies and temperature control systems. DHL Global Forwarding is now the largest mover of the air transportation containers manufactured by Envirotainer.
DHL Global Forwarding intends to expand its network of QEP certified sites for managing Envirotainers for customers at 100 locations globally by the end of 2008, achieving QEP status at every primary airport facility where the Envirotainer is used by DHL.
‘Few industries pose as much of a challenge to shipping and logistics than life sciences and healthcare. Temperature instability can impact the quality of the material, increase the product order-to-delivery cycle time, and create additional process management costs,’ said Angelos Orfanos, Vice President of Life Science and Healthcare at DHL Global Customer Solutions. ‘DHL’s capabilities for the life science and healthcare sector enable customers to safely and securely transport small or large volumes of critical vaccines, Active Pharmaceutical Ingredients (API’s), and other temperature sensitive pharmaceutical, biotech, diagnostic and medical materials.’
With the new QEP certification at airport facilities, DHL Global Forwarding has enhanced its ability to protect shipments for customers in the life sciences and healthcare industries.